Howe & Rusling’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Howe & Rusling’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5	Closed	-$1K	–	1051
2021 Q1	$1K	Sell	5 -1	-17%	-$188	﹤0.01%	937
2020 Q4	$1K	Buy	+6	New	+$672	﹤0.01%	920
2020 Q1	–	Sell	-10	Closed	-$1K	–	921
2019 Q4	$1K	Buy	+10	New	+$1.12K	﹤0.01%	817

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Howe & Rusling's GWPH Position: Q2 2021 in Review

Howe & Rusling sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 5 shares — an estimated $1K sold.

Howe & Rusling first reported a position in GWPH in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Howe & Rusling reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Howe & Rusling sold 5 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1K.
Howe & Rusling first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 3 quarters.
Howe & Rusling's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Howe & Rusling's 13F filing for Q2 2021, filed 13 Aug 2021.